Brandinium

Trademark search for:

ZEGRAMAX

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2003-08-28 — Application filed
  • 2004-02-08 — Assigned to examiner
  • 2004-02-09 — Final disposition recorded
  • 2004-08-11 — Paper received
  • 2004-08-11 — Sec. 1(b) claim deleted
  • 2004-08-30 — Paper received
  • 2004-08-30 — Unresponsive/duplicate paper received
  • 2004-09-24 — Amendment from applicant entered
  • 2005-08-11 — Suspension letter written
  • 2005-08-12 — Letter of suspension mailed
  • 2006-01-09 — Paper received
  • 2006-01-09 — Correspondence received in law office
  • 2006-01-26 — Amendment from applicant entered
  • 2006-03-17 — Suspension letter written
  • 2006-03-20 — Letter of suspension mailed
  • 2006-09-20 — Report completed suspension check case still suspended
  • 2007-04-09 — Report completed suspension check case still suspended
  • 2007-04-09 — Assigned to lie
  • 2007-07-24 — Attorney/dom.rep.revoked and/or appointed
  • 2007-07-24 — Teas revoke/app/change addr of atty/dom rep received
  • 2007-10-11 — Report completed suspension check case still suspended
  • 2008-03-14 — Assigned to examiner
  • 2008-04-17 — Report completed suspension check case still suspended
  • 2008-04-17 — Report completed suspension check case still suspended
  • 2008-10-17 — Suspension checked - to attorney for action
  • 2008-12-19 — Office action issued
  • 2008-12-19 — Office action issued
  • 2008-12-19 — Office action issued
  • 2009-07-17 — Application abandoned
  • 2009-07-17 — Application abandoned
  • 2009-07-17 — Final status recorded

Owner Information

AstraZeneca AB
SE-151, 85 Södertälje SE

Correspondent

Wm. Charles Saunders AstraZeneca Pharmaceuticals LP
1800 Concord Pike
OW2
Wilmington, DE 19850

Filing Details

Filing Date:
2003-08-28
Status Date:
2009-07-17
Category:
Pharmaceuticals
Filing Year:
2003

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.